The future of probiotics in the preterm infant

Early Human Development

Volumn 135, Issue , 2019, Pages 75-81

  Berrington, Janet Elizabeth ^a,b   Zalewski, Stefan ^a  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Mechanisms; Parents; Preterm infant; Probiotic; Trials

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ARTICLE; CLINICAL DECISION MAKING; DRUG RESEARCH; DRUG USE; EMBEDDING; HEALTH CARE SYSTEM; HUMAN; PREMATURITY; STUDY DESIGN; ATTITUDE TO HEALTH; CHILD PARENT RELATION; CLINICAL TRIAL (TOPIC); NEWBORN; PSYCHOLOGY;

CLINICAL TRIALS AS TOPIC; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PARENTS; PROBIOTICS;

EID: 85066080003     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2019.05.008     Document Type: Article

References (88)

1. Lundgrén-Laine, H., Kontio, E., Perttilä, J., Korvenranta, H., Forsström, J., Salanterä, S., Managing daily intensive care activities: an observational study concerning ad hoc decision making of charge nurses and intensivists. Crit. Care, 15(4), 2011, R188.
2. Saugstad, O.D., Sweet, D.G., Speer, C.P., et al. European consensus guidelines on the management of respiratory distress syndrome - 2016 update. Neonatology 111 (2017), 107–125.
3. Bonanno, C., Wapner, R.J., Antenatal corticosteroids in the management of preterm birth: are we back where we started?. Obstet. Gynecol. Clin. N. Am. 39 (2012), 47–63.
4. Lau, C., Chamberlain, R., Sun, S., Less invasive surfactant administration reduces the need for mechanical ventilation in preterm infants. Glob Pediatr Heal 4 (2017), 1–9.
5. Athalye-Jape, G., Patole, S., Probiotics for preterm infants – time to end all controversies. Microb. Biotechnol., 2019, 10.1111/1751-7915.13357.
6. Tarnow-Mordi, W., Soll, R.F., Probiotic supplementation in preterm infants: it is time to change practice. J Peds 12 (2014), 959–960.
7. Neu, J., Routine probiotics for premature infants: Let's be careful!. J Peds 158 (2011), 672–674.
8. Kona, S., Matlock, D., Probiotics, prebiotics, and synbiotics for preterm neonates. Neoreviews 19:11 (2018), e654–e663.
9. Abbott, J., Berrington, J., Bowler, U., et al. The speed of increasing milk feeds: a randomised controlled trial. BMC Pediatr., 17(1), 2017, 39.
10. The ELFIN investigator groupEnteral lactoferrin supplementation for very preterm infants: a randomised controlled trial. Lancet, 393, 2019, 423–433.
11. Stey, A., Barnert, E., Tseng, C.-H., et al. Outcomes and costs of surgical treatments of necrotizing enterocolitis. Pediatrics 135:5 (2015), e1190–e1197.
12. Duffield, S.D., Clarke, P., Current use of probiotics to prevent necrotising enterocolitis. Arch Dis Child - Fetal Neonatal Ed., 104(2), 2018.
13. Viswanathan, S., Lau, C., Akbari, H., Hoyen, C., Walsh, M.C., Survey and evidence based review of probiotics used in very low birth weight preterm infants within the United States. J. Perinatol. 36:12 (2016), 1106–1111.
14. Costeloe, K., Hardy, P., Juszczak, E., Wilks, M., Millar, M.R., Bifi dobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 387 (2016), 649–660.
15. Thomas, J.P., Raine, T., Reddy, S., Belteki. Probiotics for the prevention of necrotising enterocolitis in very low birth weight infants: a meta-analysis and systematic review. Acta Paediatr. 106 (2017), 1729–1741.
16. Zeilstra, D., Younes, J.A., Brummer, R.J., Kleerebezem, M., Perspective: fundamental limitations of the randomized controlled trial method in nutritional research: the example of probiotics. Adv. Nutr. 9 (2018), 561–571.
17. Cavallaro, G., Villamor-Martínez, E., Filippi, L., Mosca, F., Villamor, E., Probiotic supplementation in preterm infants does not affect the risk of retinopathy of prematurity: a meta-analysis of randomized controlled trials. Sci. Rep., 7(1), 2017, 10.1038/s41598-017-13465-2.
18. Villamor-Martínez, E., Pierro, M., Cavallaro, G., Mosca, F., Kramer, B., Villamor, E., Probiotic supplementation in preterm infants does not affect the risk of bronchopulmonary dysplasia: a meta-analysis of randomized controlled trials. Nutrients., 9(11), 2017, 1197, 10.3390/nu9111197.
19. Gori, D., Meneghin, F., Morelli, L., et al. Probiotics and time to achieve full enteral feeding in human milk-fed and formula-fed preterm infants: systematic review and meta-analysis. Nutrients., 8, 2016, 471, 10.3390/nu8080471.
20. Chang, H.Y., Chen, J.H., Chang, J.H., Lin, H.C., Lin, C.Y., Peng, C.C., Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: an updated meta-analysis. PLoS One, 12(2), 2017, e0171579.doi.10.1371/journalpone.0171579.
21. Sawh, S.C., Deshpande, S., Jansen, S., Reynaert, C.J., Jones, P.M., Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis. PeerJ, 4, 2016, e2429, 10.7717/peerj.2429.
22. Van den Akker, C., Van Goudever, J., Szajewska, H., et al. Probiotics for preterm infants: a strain specific systematic review and network meta-analysis. JPGN 67 (2018), 103–122.
23. Rothwell, P.M., Treating individuals 1 – External validity of randomised controlled trials: ‘To whom do the results of this trial apply?’. Lancet 365 (2005), 82–93.
24. Underwood, M.A., Salzman, N.H., Bennett, S.H., Barman, M., Mills, D.A., Marcobal, A., et al. A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. JPGN. 48:2 (2009), 216–225.
25. Samanta, M., Sarkar, M., Ghosh, P., Ghosh, J.K., Sinha, M.K., Chatterjee, S., Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J. Trop. Pediatr. 55:2 (2009), 128–131.
26. Hill, C., Guarner, F., Reid, G., et al. Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 11 (2014), 506–514.
27. Sanders, M.E., Benson, A., Lebeer, S., Merenstein, D.J., Klaenhammer, Shared mechanisms among probiotic taxa: implications for general probiotic claims. Curr OP. Biotech 49 (2018), 207–216.
28. Olsen, R., Schrøder, M., Prophylactic probiotics for preterm infants: a systematic review and meta-analysis of observational studies. Neonatology 109 (2016), 105–112.
29. Dermyshi, E., Wang, Y., Yan, C., et al. The “golden age” of probiotics: a systematic review and meta-analysis of randomized and observational studies in preterm infants. Neonatology. 112 (2017), 9–23.
30. Singh B, Shah PS, Afifi J et al. Probiotics for preterm infants: A National Retrospective Cohort Study. J Perinatol. 2019; 0.1038/s41372-019-0315-z.
31. Härtel, C., Pagel, J., Rupp, J., et al. Prophylactic use of lactobacillus acidophilus/bifidobacterium infantis probiotics and outcome in very low birth weight infants. J. Pediatr. 165 (2014), 285–289.
32. Samuels, N., Van den Graaf, Been, J., et al. Necrotising enterocolitis and mortality in preterm infants after introduction of probiotics: a quasi-experimental study. Sci. Rep., 6, 2016, 31643.
33. Gordon, P.V., Swanson, J.R., MacQueen, B.C., Christensen, R.D., A critical question for NEC researchers: can we create a consensus definition of NEC that facilitates research progress?. Sem Peri 41 (2017), 7–14.
34. Embleton, N.D., Turnbull, E., Turner, S., Berrington, J.E., Successful blood salvaging from preterm infants: maximizing opportunities, minimizing interventions. Acta Paediatr., 102(11), 2013, 10.1111/apa.12373.
35. Indrio, F., Riezzo, G., Tafuri, S., et al. Probiotic supplementation in preterm:feeding intolerance and hospital cost. Nutrients, 9, 2017, 965, 10.3390/nu9090965.
36. Mohan, R., Koebnick, C., Schildt, J., Mueller, M., Radke, M., Blaut, M., Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, lactate, calprotectin and IgA in preterm infants. Ped Res 64 (2008), 418–422.
37. Watkins, C., Murphy, B.P., Ryan, C.A., et al. Dose-interval study of a dual probiotic in preterm infants. Arch Dis Child - Fetal Neonatal Ed. 104 (2019), F159–F164.
38. Fofanova, T., Stewart, C.J., Auchtung, et al. A novel human enteroid-anaerobe co-culture system to study microbial-host interaction under physiological hypoxia. bioRxiv, 2019, 10.1101/555755.
39. Ventura, M., Duranti, S., Rodriguez, J.M., et al. The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol. Mol. Biol. Rev., 81(4), 2017 (e0036-17).
40. Ng, P.C., Biomarkers of necrotising enterocolitis. Sem Fet and Neo Med. 19 (2014), 33–38.
41. Ng, P.C., Ma, T.P.Y., Lam, H.S., The use of laboratory biomarkers for surveillance, diagnosis and prediction of clinical outcomes in neonatal sepsis and necrotising enterocolitis. Arch. Dis. Child. Fetal Neonatal Ed. 100 (2015), F448–F452.
42. Millar, M., Seale, J., Greenland, M., et al. The microbiome of infants recruited to a randomised placebo-controlled probiotic trial (PiPS trial). EBioMedicine 20 (2017), 255–262.
43. Plummer, E.L., Bulach, D.M., Murray, G.L., Jacobs, S.E., Tabrizi, S.N., Garland, S.M., Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial. BMC Microbiol., 18, 2018, 184.
44. Pammi, M., Cope, J., Tarr, P.I., et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome., 5, 2017, 31.
45. Ma, B., Mccomb, E., Gajer, P., et al. Microbial biomarkers of intestinal barrier maturation in preterm infants. Front. Microbiol., 9, 2018, 2755, 10.3389/fmicb.2018.02755.
46. Stewart, C.J., Embleton, N.D., Marrs, E.C.L., et al. Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease. Microbiome, 4, 2016, 67, 10.1186/s40168-016-0216-8.
47. Wandro S, Osborne S, Enriquez C et al. The Microbiome and Metabolome of Preterm Infant Stool Are Personalized and Not Driven by Health Outcomes, Including Necrotizing Enterocolitis and Late-Onset Sepsis mSphere 3;e00104–18.
48. Dutta, S., Ray, P., Narang, A., Comparison of stool colonization in premature infants by three dose regimes of a probiotic combination: a randomized controlled trial. Am. J. Perinatol. 8 (2015), 733–740.
49. Abdulkadir, B., Nelson, A., Skeath, T., et al. Stool bacterial load in preterm infants with necrotising enterocolitis. Early Hum. Dev. 95 (2016), 1–2.
50. Underwood, M.A., Kalanetra, K.M., Bokulich, N.A., et al. A comparison of two probiotic strains of bifidobacteria in premature infants. J. Pediatr. 163 (2013), 1585–1591.
51. Guthmann, F., Arlettaz Mieth, R.P., Bucher, H.U., Bührer, C., Short courses of dual-strain probiotics appear to be effective in reducing necrotising enterocolitis. Acta Paediatr. 105 (2016), 255–259.
52. Thomas, D., Greer, F., Clinical report - probiotics and proebiotics in pediatrics. Pediatrics 126 (2010), 1217–1231.
53. Braegger, C., Chmielewska, A., Decsi, T., et al. Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition. JPGN 52 (2011), 238–250.
54. Sanders, M.E., Shane, A.L., Merenstein, D.J., Advancing probiotic research in humans in the United States: challenges and strategies. Gut Microbes 7:2 (2016), 97–100.
55. Pettoello-Mantovani, M., Hojsak, I., Fabiano, V., et al. European guidance on paediatric use of probiotics states that benefits are limited to several conditions and urges caution with specific vulnerable groups. Acta Paediatr. 107 (2018), 927–937.
56. Kolaček, S., Hojsak, I., Berni Canani, R., et al. Commercial probiotic products: a call for improved quality control. A position paper by the ESPGHAN working group for probiotics and prebiotics. JPGN 65:1 (2017), 117–124.
57. Sullivan, A., Nord, C.E., Probiotic lactobacilli and bacteraemia in Stockholm. Scan J Infect Dis(5), 2006, 327–331.
58. Vallabheni, S., Walker, T.A., Lockhart, S.R., et al. Fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement. MMWR 64:6 (2015), 155–156.
59. Zingg, W., Tomaske, M., Martin, M., Risk of parenteral nutrition in neonates—an overview. Nutrients, 4, 2012 (1490-03).
60. Vergnano, S., Menson, E., Kennea, N., et al. Neonatal infections in England: the neonIN surveillance network. Arch. Dis. Child. Fetal Neonatal Ed., 96(1), 2011.
61. Pedersen, T., Klingenberg, C., Hjerde, E., et al. Effects of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants. Front. Pediatr., 6, 2018, 347, 10.3389/fped.2018.00347.
62. Upadhyay, R.P., Taneja, S., Chowdhury, R., Strand, T.A., Bhandari, N., Effect of prebiotic and probiotic supplementation on neurodevelopment in preterm very low birth weight infants: findings from a meta-analysis. Pedaitr Res., 2018, 10.1038/s41390-018-0211-9.
63. Sesham R and Clarke P. What do parents think about probiotic use in preterm infants. Arch. Dis. Child. 99(S2):A448.
64. Gadapalli, S., Canvasser, J., Eskenazi, Y., Quinn, M., Kim, J., Gephart, S., Roles and experiences of parents in necrotizing enterocolitis: an international survey of parental perspectives of communication in the NICU. Adv Neo Care. 17 (2017), 489–498.
65. Bridgman, S.L., Azad, M.B., Field, C.J., et al. Maternal perspectives on the use of probiotics in infants: a cross-sectional survey. BMC Complement. Altern. Med., 14, 2014, 366.
66. Umberger, E., Canvasser, J., Hall, S.L., Enhancing NICU parent engagement and empowerment. Semin. Pediatr. Surg. 27 (2018), 19–24.
67. Clarke, M., Loudon, K., Effects on patients of their healthcare practitioner's or institution's participation in clinical trials: a systematic review. Trials, 12, 2011, 16.
68. Djulbegovic, B., Kumar, A., Glasziou, P., Miladinovic, B.C.I., Trial unpredictability yields predictable therapeutic gains. Nature 500 (2013), 395–396.
69. Zmora, N., Zilberman-Schapira, G., Suez, J., et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. 174 (2018), 1388–1405.
70. Tarnow-Mordi, W., Cruz, M., Morris, J., Mol, B.W., RCT evidence should drive clinical practice: a day without randomisation is a day without progress. BJOG., 2017, 613.
71. Neu, J., Shuster, J., Nonadministration of routine probiotics unethical—really?. Pediatrics, 126, 2010, e740.
72. Mhaskar, R., Bercu, B.B., Djulbegovic, B., At what level of collective equipoise does a randomized clinical trial become ethical for the members of institutional review board/ethical committees?. Acta Inform Med. 21 (2013), 156–159.
73. Loudon, K., Treweek, S., Sullivan, F., Donnan, P., Thorpe, K.E., Zwarenstein, M., The PRECIS-2 tool: designing trials that are fit for purpose. BMJ., 350, 2015, h2147.
74. Turner, E.L., Prague, M., Gallis, J.A., Li, F., Murray, D.M., Review of recent methodological developments in group-randomized trials: part 2—analysis. AJPH. 107 (2017), 1078–1086.
75. Battersby, C., Longford, N., Mandalia, S., Costeloe, K., Modi, N., Incidence and enteral feed antecedents of severe neonatal necrotising enterocolitis across neonatal networks in England, 2012–13: a whole-population surveillance study. Lancet Gastroenterol Hepatol. 2 (2017), 43–51.
76. Deshpande, G., Jape, G., Rao, S., Patole, S., Benefits of probiotics in preterm neonates in low-income and medium- income countries: a systematic review of randomised controlled trials. BMJ Open 7 (2017), 1–15, 10.1136/bmjopen-2017-0176382017 e017638.
77. Angus, D.C., Fusing randomized trials with big data: the key to self-learning health care systems?. JAMA 314 (2015), 767–768.
78. Grumbach, K., Lucey, C.R., Johnston, S.C., Transforming from centers of learning to learning health systems: the challenge for academic health centers. JAMA 311 (2014), 1109–1110.
79. Gale, C., Hyde, M.J., Modi, N., Research ethics committee decision-making in relation to an efficient neonatal trial. Arch. Dis. Child. Fetal Neonatal Ed. 102 (2017), F291–F298.
80. Berry, S.M., Connor, J.T., Lewis, R.J., The platform trial: an efficient strategy for evaluating multiple treatments. JAMA 313 (2015), 1619–1620.
81. Embleton, N.D., Berrington JE Dorling, J., et al. Mechanisms affecting the gut of Preterm infants in enteral Feeding trials. Front. Nutr., 4, 2017, 14, 10.3389/fnut.2017.00014.
82. Ganguli, K., Meng, D., Rautava, S., Lu, L., Walker, W., Nanthakumar, N., Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 304 (2013), G132–G141.
83. Autran, C.A., Kellman, B.P., Kim, J.H., et al. Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants. Gut, 67, 2017, 6.
84. Meyer, K.M., Mohammad, M., Autran, C., Bode, L., Haymond, M., Aagaard, K., Maternal secretor status and the milk microbiota composition. Am. J. Obstet. Gynecol., S180, 2018, 283.
85. Taverniti, V., Guglielmetti, S., The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr. 6 (2011), 261–274.
86. Sugahara, H., Yao, R., Odamaki, T., Xiao, J.Z., Differences between live and heat-killed bifidobacteria in the regulation of immune function and the intestinal environment. Benef Microbes. 8 (2017), 463–472.
87. Zorzela, L., Ardestani, S.K., McFarland, L.V., Vohra, S., Is there a role for modified probiotics as beneficial microbes: a systematic review of the literature. Benef Microbes 8 (2017), 739–754.
88. Deshpande, G., Athalye-Jape, G., Patole, S., Para-probiotics for preterm neonates—the next frontier. Nutrients 10 (2018), 871–880.